verapamil has been researched along with sphingosine 1-phosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpio, LC; Dziak, R; Kamer, A; Stephan, E | 1 |
Alemany, R; Danneberg, K; Hashemi, R; Jakobs, KH; Kleuser, B; Lass, H; Meyer zu Heringdorf, D; Ruwisch, L; Spiegel, S | 1 |
Campos, CR; Cannon, RE; Hawkins, BT; Miller, DS; Peart, JC | 1 |
3 other study(ies) available for verapamil and sphingosine 1-phosphate
Article | Year |
---|---|
Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells.
Topics: Animals; Calcium Channel Blockers; Calcium Signaling; Cell Division; Cells, Cultured; Ceramides; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Lysophospholipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Osteoblasts; Rats; Sphingolipids; Sphingosine; Verapamil | 1999 |
Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate.
Topics: Animals; Bradykinin; Calcium Channels; Calcium Signaling; Cell Membrane; Lysophospholipids; Norepinephrine; PC12 Cells; Phosphotransferases (Alcohol Group Acceptor); Potassium Chloride; Rats; Recombinant Proteins; Sphingosine; Verapamil | 2001 |
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blood-Brain Barrier; Calcium Channel Blockers; Capillaries; Drug Delivery Systems; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Lysophospholipids; Nerve Tissue Proteins; Organophosphates; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingolipids; Sphingosine; Tight Junctions; Tumor Necrosis Factor-alpha; Verapamil | 2012 |